Exergame Balance Training for Patients With Mild Cognitive Impairment

Exergame Balance Training for Pre Frontal Brain Activity and Executive Functioning in Patients With Mild Cognitive Impairment

This study will be a randomized control trial, which will be conducted on older adults with mild cognitive impairment. A specially designed Exergame balance training will be used for cognitive enhancement in patients with MCI. This training will determine the improvement in executive functioning, balance, speech and electrical activity of the brain.

From last few years the line of research for cognitive enhancement has been shifted towards balance training as balance training is considered to directly stimulate the neuronal activity as compare to aerobic training. The previous finding also proposed that in aerobic training it is the intensity of training that improves the neuroplasticity and cognition but it is the neuro-cognitive demands and complexity of the task in balance training that affects the relationship between exercise and cognition in balance training. There is a need to determine the effect of the level of complexity of balance training on neural activity and executive functioning. Exergame augmented balance training is expected to have a better physical and cognitive outcome as compared to traditional balance training.

Inclusion Criteria:

• Age ≥ 55
• MoCA =20-24
• CDR ( dementia rating scale)≤ 1.0
• No unstable disease precluding planned exercise.
• Able to see and hear sufficiently to participate in planned physical and computer-based cognitive training.
• Patients score >45 on Berg Balance Scale.

Exclusion Criteria:

• Participation in any cognitive training activity
• Participation in > 150 min/wk of moderate or greater intensity planned exercise of any kind.
• Non-ambulatory or major mobility disorder.
• Other neurological conditions associated with cognitive impairment such as stroke, Parkinson disease, and head injury
• Any clinically significant psychiatric condition, current drug or alcohol abuse, or laboratory abnormality that would interfere with the ability to participate in the study.
• Individual with any musculoskeletal impairment.
• Unwillingness to participate.